How can citrus bergamia (bergamot) extract be used to lower LDL‑C, including recommended dose, expected reduction, monitoring, and contraindications?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bergamot extract is a reasonable adjunctive nutraceutical option for mild-to-moderate LDL-C elevation, typically reducing LDL-C by 10-15% at doses of 150 mg flavonoids daily, though it should not replace statin therapy in high-risk patients requiring guideline-directed medical therapy.

Current cardiovascular guidelines do not specifically endorse bergamot extract, but they do acknowledge plant stanols/sterols and dietary approaches as adjuncts to LDL-lowering therapy
1
,
2
. The 2022 ACC Expert Consensus recognizes nonstatin therapies for patients unable to achieve LDL-C goals, though bergamot is not specifically listed among FDA-approved agents
3
.

Key principle: For low-risk adults (0-1 risk factors) with LDL-C around 100 mg/dL, no pharmacologic therapy is indicated as this is well below the 160 mg/dL intervention threshold
4
. Bergamot would be considered only when LDL-C rises above goal for the patient’s risk category.

Multiple randomized controlled trials demonstrate consistent lipid-lowering effects:

Standard dose: 150 mg of standardized flavonoids daily
5
,
6
,
9